Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Liabilities (2016 - 2025)

Collegium Pharmaceutical has reported Total Liabilities over the past 10 years, most recently at $1.4 billion for Q4 2025.

  • Quarterly results put Total Liabilities at $1.4 billion for Q4 2025, down 5.55% from a year ago — trailing twelve months through Dec 2025 was $1.4 billion (down 5.55% YoY), and the annual figure for FY2025 was $1.4 billion, down 5.55%.
  • Total Liabilities for Q4 2025 was $1.4 billion at Collegium Pharmaceutical, up from $1.3 billion in the prior quarter.
  • Over the last five years, Total Liabilities for COLL hit a ceiling of $1.4 billion in Q4 2024 and a floor of $460.7 million in Q2 2021.
  • Median Total Liabilities over the past 5 years was $1.0 billion (2022), compared with a mean of $1.0 billion.
  • Biggest five-year swings in Total Liabilities: soared 127.49% in 2022 and later fell 17.4% in 2024.
  • Collegium Pharmaceutical's Total Liabilities stood at $489.1 million in 2021, then skyrocketed by 100.2% to $979.3 million in 2022, then fell by 3.21% to $947.9 million in 2023, then skyrocketed by 51.36% to $1.4 billion in 2024, then dropped by 5.55% to $1.4 billion in 2025.
  • The last three reported values for Total Liabilities were $1.4 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.